{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:01:38Z","timestamp":1793908898845,"version":"4.8.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41585-020-0332-x","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T12:02:57Z","timestamp":1591963377000},"page":"407-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":200,"title":["Genetics of kidney stone disease"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-0895","authenticated-orcid":false,"given":"Sarah A.","family":"Howles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-3220","authenticated-orcid":false,"given":"Rajesh V.","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"332_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","volume":"62","author":"CD Scales","year":"2012","unstructured":"Scales, C. D. et al. Prevalence of kidney stones in the United States. Eur. Urol. 62, 160\u2013165 (2012).","journal-title":"Eur. Urol."},{"key":"332_CR2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/bju.13520","volume":"118","author":"H Heers","year":"2016","unstructured":"Heers, H. & Turney, B. W. Trends in urological stone disease: a 5-year update of hospital episode statistics. BJU Int. 118, 785\u2013789 (2016).","journal-title":"BJU Int."},{"key":"332_CR3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.2003.00917.x","volume":"63","author":"KK Stamatelou","year":"2003","unstructured":"Stamatelou, K. K., Francis, M. E., Jones, C. A., Nyberg, L. M. & Curhan, G. C. Time trends in reported prevalence of kidney stones in the United States: 1976\u20131994. Kidney Int. 63, 1817\u20131823 (2003).","journal-title":"Kidney Int."},{"key":"332_CR4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","volume":"192","author":"MS Pearle","year":"2014","unstructured":"Pearle, M. S. et al. Medical management of kidney stones: AUA Guideline. J. Urol. 192, 316\u2013324 (2014).","journal-title":"J. Urol."},{"key":"332_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.juro.2016.12.135","volume":"198","author":"G Gambaro","year":"2017","unstructured":"Gambaro, G. et al. The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J. Urol. 198, 268\u2013273 (2017).","journal-title":"J. Urol."},{"key":"332_CR6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2215\/CJN.00560112","volume":"7","author":"DS Goldfarb","year":"2012","unstructured":"Goldfarb, D. S. A woman with recurrent calcium phosphate kidney stones. Clin. J. Am. Soc. Nephrol. 7, 1172\u20131178 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"332_CR7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/postgradmedj-2017-135332","volume":"94","author":"Q Ma","year":"2018","unstructured":"Ma, Q. et al. Uric acid stones, clinical manifestations and therapeutic considerations. Postgrad. Med. J. 94, 458\u2013462 (2018).","journal-title":"Postgrad. Med. J."},{"key":"332_CR8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI26662","volume":"115","author":"FL Coe","year":"2005","unstructured":"Coe, F. L. Kidney stone disease. J. Clin. Invest. 115, 2598\u20132608 (2005).","journal-title":"J. Clin. Invest."},{"key":"332_CR9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrurol.2014.51","volume":"11","author":"K Thomas","year":"2014","unstructured":"Thomas, K., Wong, K., Withington, J., Bultitude, M. & Doherty, A. Cystinuria\u2014a urologist\u2019s perspective. Nat. Rev. Urol. 11, 270\u2013277 (2014).","journal-title":"Nat. Rev. Urol."},{"key":"332_CR10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrneph.2016.101","volume":"12","author":"FL Coe","year":"2016","unstructured":"Coe, F. L., Worcester, E. M. & Evan, A. P. Idiopathic hypercalciuria and formation of calcium renal stones. Nat. Rev. Nephrol. 12, 519\u2013533 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"332_CR11","first-page":"1151","volume":"14","author":"M Daudon","year":"2004","unstructured":"Daudon, M. et al. Composition of renal stones currently observed in non-industrialized countries. Prog. Urol. 14, 1151\u20131161 (2004).","journal-title":"Prog. Urol."},{"key":"332_CR12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/01.ASN.0000062960.26868.17","volume":"14","author":"KK Frick","year":"2003","unstructured":"Frick, K. K. Molecular mechanisms of primary hypercalciuria. J. Am. Soc. Nephrol. 14, 1082\u20131095 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM196806132782403","volume":"278","author":"M Resnick","year":"1968","unstructured":"Resnick, M., Pridgen, D. B. & Goodman, H. O. Genetic predisposition to formation of calcium oxalate renal calculi. N. Engl. J. Med. 278, 1313\u20131318 (1968).","journal-title":"N. Engl. J. Med."},{"key":"332_CR14","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1681\/ASN.V8101568","volume":"8","author":"GC Curhan","year":"1997","unstructured":"Curhan, G. C., Willett, W. C., Rimm, E. B. & Stampfer, M. J. Family history and risk of kidney stones. J. Am. Soc. Nephrol. 8, 1568\u20131573 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ekir.2018.11.017","volume":"4","author":"DS Goldfarb","year":"2019","unstructured":"Goldfarb, D. S., Avery, A. R., Beara-Lasic, L., Duncan, G. E. & Goldberg, J. A twin study of genetic influences on nephrolithiasis in women and men. Kidney Int. Rep. 4, 535\u2013540 (2019).","journal-title":"Kidney Int. Rep."},{"key":"332_CR16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1523-1755.2005.00170.x","volume":"67","author":"DS Goldfarb","year":"2005","unstructured":"Goldfarb, D. S., Fischer, M. E., Keich, Y. & Goldberg, J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 67, 1053\u20131061 (2005).","journal-title":"Kidney Int."},{"key":"332_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/cs1030259","volume":"103","author":"DJ Hunter","year":"2002","unstructured":"Hunter, D. J. et al. Genetic contribution to renal function and electrolyte balance: a twin study. Clin. Sci. 103, 259\u2013265 (2002).","journal-title":"Clin. Sci."},{"key":"332_CR18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/bju.14096","volume":"121","author":"K Hemminki","year":"2018","unstructured":"Hemminki, K. et al. Familial risks in urolithiasis in the population of Sweden. BJU Int. 121, 479\u2013485 (2018).","journal-title":"BJU Int."},{"key":"332_CR19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.2014040388","volume":"26","author":"J Halbritter","year":"2015","unstructured":"Halbritter, J. et al. Fourteen monogenic genes account for 15% of nephrolithiasis\/nephrocalcinosis. J. Am. Soc. Nephrol. 26, 543\u2013551 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.kint.2017.06.025","volume":"93","author":"A Daga","year":"2018","unstructured":"Daga, A. et al. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 93, 204\u2013213 (2018).","journal-title":"Kidney Int."},{"key":"332_CR21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2215\/CJN.07540715","volume":"11","author":"DA Braun","year":"2016","unstructured":"Braun, D. A. et al. Prevalence of monogenic causes in pediatric patients with nephrolithiasis or nephrocalcinosis. Clin. J. Am. Soc. Nephrol. 11, 664\u2013672 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"332_CR22","unstructured":"T\u00fcrk, C. et al. Guidelines on urolithiasis. Eur. Urol. https:\/\/uroweb.org\/guideline\/urolithiasis (2020)."},{"key":"332_CR23","unstructured":"Pearle, M. S. et al. Medical management of kidney stones. AUA https:\/\/www.auanet.org\/guidelines\/kidney-stones-medical-mangement-guideline (2019)."},{"key":"332_CR24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bju.14654","volume":"123","author":"NICE Guideline","year":"2019","unstructured":"NICE Guideline. Renal and ureteric stones: assessment and management. BJU Int. 123, 220\u2013232 (2019).","journal-title":"BJU Int."},{"key":"332_CR25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-5347(01)66321-3","volume":"155","author":"L Borghi","year":"1996","unstructured":"Borghi, L. et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J. Urol. 155, 839\u2013843 (1996).","journal-title":"J. Urol."},{"key":"332_CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10654-014-9904-5","volume":"29","author":"BW Turney","year":"2014","unstructured":"Turney, B. W. et al. Diet and risk of kidney stones in the Oxford cohort of the European prospective investigation into cancer and nutrition (EPIC). Eur. J. Epidemiol. 29, 363\u2013369 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"332_CR27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1523-1755.2003.00807.x","volume":"63","author":"R Siener","year":"2003","unstructured":"Siener, R., Ebert, D., Nicolay, C. & Hesse, A. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int. 63, 1037\u20131043 (2003).","journal-title":"Kidney Int."},{"key":"332_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eururo.2009.03.031","volume":"56","author":"HA Fink","year":"2009","unstructured":"Fink, H. A. et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur. Urol. 56, 72\u201380 (2009).","journal-title":"Eur. Urol."},{"key":"332_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/gfu243","volume":"31","author":"A Ticinesi","year":"2016","unstructured":"Ticinesi, A., Nouvenne, A., Maalouf, N. M., Borghi, L. & Meschi, T. Salt and nephrolithiasis. Nephrol. Dial. Transpl. 31, 39\u201345 (2016).","journal-title":"Nephrol. Dial. Transpl."},{"key":"332_CR30","doi-asserted-by":"crossref","first-page":"F592","DOI":"10.1152\/ajprenal.00116.2013","volume":"305","author":"KJ Bergsland","year":"2013","unstructured":"Bergsland, K. J., Worcester, E. M. & Coe, F. L. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am. J. Physiol. Renal Physiol. 305, F592\u2013F599 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"332_CR31","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1046\/j.1523-1755.2001.00746.x","volume":"59","author":"GC Curhan","year":"2001","unstructured":"Curhan, G. C., Willett, W. C., Speizer, F. E. & Stampfer, M. J. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 59, 2290\u20132298 (2001).","journal-title":"Kidney Int."},{"key":"332_CR32","first-page":"3907","volume":"84","author":"BY Reed","year":"1999","unstructured":"Reed, B. Y., Heller, H. J., Gitomer, W. L. & Pak, C. Y. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J. Clin. Endocrinol. Metab. 84, 3907\u20133913 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"332_CR33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.V1051007","volume":"10","author":"P Scott","year":"1999","unstructured":"Scott, P. et al. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J. Am. Soc. Nephrol. 10, 1007\u20131013 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR34","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1210\/jcem.87.4.8300","volume":"87","author":"BY Reed","year":"2002","unstructured":"Reed, B. Y. et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J. Clin. Endocrinol. Metab. 87, 1476\u20131485 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"332_CR35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ndt\/gfh754","volume":"20","author":"MTF Wolf","year":"2005","unstructured":"Wolf, M. T. F. et al. Mapping a new suggestive gene locus for autosomal dominant nephrolithiasis to chromosome 9q33.2\u2013q34.2 by total genome search for linkage. Nephrol. Dial. Transpl. 20, 909\u2013914 (2005).","journal-title":"Nephrol. Dial. Transpl."},{"key":"332_CR36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","volume":"335","author":"SH Pearce","year":"1996","unstructured":"Pearce, S. H. et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N. Engl. J. Med. 335, 1115\u20131122 (1996).","journal-title":"N. Engl. J. Med."},{"key":"332_CR37","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","volume":"368","author":"MA Nesbit","year":"2013","unstructured":"Nesbit, M. A. et al. Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia. N. Engl. J. Med. 368, 2476\u20132486 (2013).","journal-title":"N. Engl. J. Med."},{"key":"332_CR38","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/hmg\/ddy263","volume":"27","author":"CM Gorvin","year":"2018","unstructured":"Gorvin, C. M. et al. Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias. Hum. Mol. Genet. 27, 3720\u20133733 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"332_CR39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91103","volume":"2","author":"CM Gorvin","year":"2017","unstructured":"Gorvin, C. M. et al. G\u03b111 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy. JCI Insight 2, e91103 (2017).","journal-title":"JCI Insight"},{"key":"332_CR40","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","volume":"57","author":"FM Hannan","year":"2016","unstructured":"Hannan, F. M., Babinsky, V. N. & Thakker, R. V. Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis. J. Mol. Endocrinol. 57, R127\u2013R142 (2016).","journal-title":"J. Mol. Endocrinol."},{"key":"332_CR41","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1210\/jcem.85.12.7035","volume":"85","author":"M Yamamoto","year":"2000","unstructured":"Yamamoto, M., Akatsu, T., Nagase, T. & Ogata, E. Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders? J. Clin. Endocrinol. Metab. 85, 4583\u20134591 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"332_CR42","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/01.ASN.0000025781.16723.68","volume":"13","author":"R Vargas-Poussou","year":"2002","unstructured":"Vargas-Poussou, R. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J. Am. Soc. Nephrol. 13, 2259\u20132266 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(02)09842-2","volume":"360","author":"S Watanabe","year":"2002","unstructured":"Watanabe, S. et al. Association between activating mutations of calcium-sensing receptor and Bartter\u2019s syndrome. Lancet 360, 692\u2013694 (2002).","journal-title":"Lancet"},{"key":"332_CR44","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00467-010-1615-x","volume":"25","author":"R Bogdanovi\u0107","year":"2010","unstructured":"Bogdanovi\u0106, R. et al. A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatr. Nephrol. 25, 2363\u20132368 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1681\/ASN.2008010102","volume":"20","author":"AGH Janssen","year":"2009","unstructured":"Janssen, A. G. H. et al. Disease-causing dysfunctions of Barttin in Bartter syndrome type IV. J. Am. Soc. Nephrol. 20, 145\u2013153 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR46","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00467-011-1871-4","volume":"26","author":"HW Seyberth","year":"2011","unstructured":"Seyberth, H. W. & Schlingmann, K. P. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr. Nephrol. 26, 1789\u20131802 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/379445a0","volume":"379","author":"SE Lloyd","year":"1996","unstructured":"Lloyd, S. E. et al. A common molecular basis for three inherited kidney stone diseases. Nature 379, 445\u2013449 (1996).","journal-title":"Nature"},{"key":"332_CR48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/427887","volume":"76","author":"RR Hoopes Jr","year":"2005","unstructured":"Hoopes, R. R. Jr et al. Dent disease with mutations in OCRL1. Am. J. Hum. Genet. 76, 260\u2013267 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"332_CR49","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00467-012-2329-z","volume":"28","author":"VO Edvardsson","year":"2013","unstructured":"Edvardsson, V. O. et al. Hereditary causes of kidney stones and chronic kidney disease. Pediatr. Nephrol. 28, 1923\u20131942 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR50","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-28","volume":"5","author":"O Devuyst","year":"2010","unstructured":"Devuyst, O. & Thakker, R. V. Dent\u2019s disease. Orphanet J. Rare Dis. 5, 28 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"332_CR51","first-page":"473","volume":"87","author":"OM Wrong","year":"1994","unstructured":"Wrong, O. M., Norden, A. G. & Feest, T. G. Dent\u2019s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87, 473\u2013493 (1994).","journal-title":"QJM"},{"key":"332_CR52","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1073\/pnas.1302063110","volume":"110","author":"CM Gorvin","year":"2013","unstructured":"Gorvin, C. M. et al. Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients. Proc. Natl Acad. Sci. USA 110, 7014\u20137019 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"332_CR53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/tra.12160","volume":"15","author":"ZB Mehta","year":"2014","unstructured":"Mehta, Z. B., Pietka, G. & Lowe, M. The cellular and physiological functions of the Lowe syndrome protein OCRL1. Traffic 15, 471\u2013487 (2014).","journal-title":"Traffic"},{"key":"332_CR54","first-page":"164","volume":"83","author":"CU Lowe","year":"1952","unstructured":"Lowe, C. U., Terrey, M. & MacLachlan, E. A. Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity. AMA Am. J. Dis. Child. 83, 164\u2013184 (1952).","journal-title":"AMA Am. J. Dis. Child."},{"key":"332_CR55","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2215\/CJN.00520108","volume":"3","author":"D Bockenhauer","year":"2008","unstructured":"Bockenhauer, D. et al. Renal phenotype in Lowe syndrome: a selective proximal tubular dysfunction. Clin. J. Am. Soc. Nephrol. 3, 1430\u20131436 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"332_CR56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.21391","volume":"32","author":"H Hichri","year":"2011","unstructured":"Hichri, H. et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum. Mutat. 32, 379\u2013388 (2011).","journal-title":"Hum. Mutat."},{"key":"332_CR57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/hmg\/2.4.461","volume":"2","author":"AM Leahey","year":"1993","unstructured":"Leahey, A. M., Charnas, L. R. & Nussbaum, R. L. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. Hum. Mol. Genet. 2, 461\u2013463 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"332_CR58","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/j.ajkd.2008.08.021","volume":"52","author":"A Blanchard","year":"2008","unstructured":"Blanchard, A. et al. Effect of hydrochlorothiazide on urinary calcium excretion in Dent disease: an uncontrolled trial. Am. J. Kidney Dis. 52, 1084\u20131095 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"332_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00467-018-3965-8","volume":"33","author":"M Alonso-Varela","year":"2018","unstructured":"Alonso-Varela, M. et al. Distal renal tubular acidosis. Clinical manifestations in patients with different underlying gene mutations. Pediatr. Nephrol. 33, 1\u20137 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.ackd.2018.05.007","volume":"25","author":"DG Fuster","year":"2018","unstructured":"Fuster, D. G. & Moe, O. W. Incomplete distal renal tubular acidosis and kidney stones. Adv. Chronic Kidney Dis. 25, 366\u2013374 (2018).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"332_CR61","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1046\/j.1523-1755.2002.00656.x","volume":"62","author":"S Domrongkitchaiporn","year":"2002","unstructured":"Domrongkitchaiporn, S. et al. Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis. Kidney Int. 62, 2160\u20132166 (2002).","journal-title":"Kidney Int."},{"key":"332_CR62","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cge.13418","volume":"94","author":"N Rungroj","year":"2018","unstructured":"Rungroj, N. et al. Distal renal tubular acidosis caused by tryptophan-aspartate repeat domain 72 (WDR72) mutations. Clin. Genet. 94, 409\u2013418 (2018).","journal-title":"Clin. Genet."},{"key":"332_CR63","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2017080840","volume":"29","author":"S Enerb\u00e4ck","year":"2018","unstructured":"Enerb\u00e4ck, S. et al. Acidosis and deafness in patients with recessive mutations in FOXI1. J. Am. Soc. Nephrol. 29, 1041\u20131048 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/oxfordjournals.ndt.a092145","volume":"7","author":"B Agroyannis","year":"1992","unstructured":"Agroyannis, B., Koutsikos, D., Tzanatos-Exarchou, H. & Yatzidis, H. Erythrocytosis in type I renal tubular acidosis with nephrocalcinosis. Nephrol. Dial. Transpl. 7, 365\u2013366 (1992).","journal-title":"Nephrol. Dial. Transpl."},{"key":"332_CR65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1523-1755.2002.00417.x","volume":"62","author":"O Wrong","year":"2002","unstructured":"Wrong, O., Bruce, L. J., Unwin, R. J., Toye, A. M. & Tanner, M. J. A. Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis. Kidney Int. 62, 10\u201319 (2002).","journal-title":"Kidney Int."},{"key":"332_CR66","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1046\/j.1523-1755.1999.00756.x","volume":"56","author":"S Vasuvattakul","year":"1999","unstructured":"Vasuvattakul, S. et al. Autosomal recessive distal renal tubular acidosis associated with Southeast Asian ovalocytosis. Kidney Int. 56, 1674\u20131682 (1999).","journal-title":"Kidney Int."},{"key":"332_CR67","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1172\/JCI4836","volume":"102","author":"VS Tanphaichitr","year":"1998","unstructured":"Tanphaichitr, V. S. et al. Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin A. J. Clin. Invest. 102, 2173\u20132179 (1998).","journal-title":"J. Clin. Invest."},{"key":"332_CR68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/5022","volume":"21","author":"FE Karet","year":"1999","unstructured":"Karet, F. E. et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat. Genet. 21, 84\u201390 (1999).","journal-title":"Nat. Genet."},{"key":"332_CR69","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1086\/302679","volume":"65","author":"FE Karet","year":"1999","unstructured":"Karet, F. E. et al. Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34. Am. J. Hum. Genet. 65, 1656\u20131665 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"332_CR70","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1681\/ASN.2015040367","volume":"27","author":"NA Dhayat","year":"2016","unstructured":"Dhayat, N. A. et al. The vacuolar H+-ATPase B1 subunit polymorphism p.E161K associates with impaired urinary acidification in recurrent stone formers. J. Am. Soc. Nephrol. 27, 1544\u20131554 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR71","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1681\/ASN.2016050576","volume":"28","author":"JA Sayer","year":"2017","unstructured":"Sayer, J. A. Progress in understanding the genetics of calcium-containing nephrolithiasis. J. Am. Soc. Nephrol. 28, 748\u2013759 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR72","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ekir.2017.06.009","volume":"2","author":"BK Canales","year":"2017","unstructured":"Canales, B. K. et al. Polymorphisms in renal ammonia metabolism genes correlate with 24-hour urine pH. Kidney Int. Rep. 2, 1111\u20131121 (2017).","journal-title":"Kidney Int. Rep."},{"key":"332_CR73","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2005121305","volume":"17","author":"R Vargas-Poussou","year":"2006","unstructured":"Vargas-Poussou, R. et al. Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J. Am. Soc. Nephrol. 17, 1437\u20131443 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00467-016-3520-4","volume":"32","author":"MTP Besouw","year":"2017","unstructured":"Besouw, M. T. P. et al. Clinical and molecular aspects of distal renal tubular acidosis in children. Pediatr. Nephrol. 32, 1\u201310 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR75","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.kint.2016.12.017","volume":"91","author":"V Palazzo","year":"2017","unstructured":"Palazzo, V. et al. The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int. 91, 1243\u20131255 (2017).","journal-title":"Kidney Int."},{"key":"332_CR76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM198503073121003","volume":"312","author":"M Tieder","year":"1985","unstructured":"Tieder, M. et al. Hereditary hypophosphatemic rickets with hypercalciuria. N. Engl. J. Med. 312, 611\u2013617 (1985).","journal-title":"N. Engl. J. Med."},{"key":"332_CR77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bone.2013.11.008","volume":"59","author":"Y Chi","year":"2014","unstructured":"Chi, Y. et al. A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient. Bone 59, 114\u2013121 (2014).","journal-title":"Bone"},{"key":"332_CR78","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.2013101085","volume":"25","author":"D Dasgupta","year":"2014","unstructured":"Dasgupta, D. et al. Mutations in SLC34A3\/NPT2c are associated with kidney stones and nephrocalcinosis. J. Am. Soc. Nephrol. 25, 2366\u20132375 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR79","first-page":"e0193388 17","volume":"13","author":"S Acar","year":"2018","unstructured":"Acar, S. et al. Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: novel Mutations in PHEX and SLC34A3. PLoS One 13, e0193388 17 (2018).","journal-title":"PLoS One"},{"key":"332_CR80","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2012.12.003","volume":"53","author":"V Braithwaite","year":"2013","unstructured":"Braithwaite, V., Pettifor, J. M. & Prentice, A. Novel SLC34A3 mutation causing hereditary hypophosphataemic rickets with hypercalciuria in a Gambian family. Bone 53, 216\u2013220 (2013).","journal-title":"Bone"},{"key":"332_CR81","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","volume":"347","author":"D Pri\u00e9","year":"2002","unstructured":"Pri\u00e9, D. et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N. Engl. J. Med. 347, 983\u2013991 (2002).","journal-title":"N. Engl. J. Med."},{"key":"332_CR82","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","volume":"95","author":"L Beck","year":"1998","unstructured":"Beck, L. et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl Acad. Sci. USA 95, 5372\u20135377 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"332_CR83","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","volume":"27","author":"KP Schlingmann","year":"2016","unstructured":"Schlingmann, K. P. et al. Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2\u2009A cause idiopathic infantile hypercalcemia. J. Am. Soc. Nephrol. 27, 604\u2013614 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR84","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8975","volume":"6","author":"A Oddsson","year":"2015","unstructured":"Oddsson, A. et al. Common and rare variants associated with kidney stones and biochemical traits. Nat. Commun. 6, 7975 (2015).","journal-title":"Nat. Commun."},{"key":"332_CR85","doi-asserted-by":"crossref","first-page":"e1002541 7","DOI":"10.1371\/journal.pgen.1002541","volume":"8","author":"Y Urabe","year":"2012","unstructured":"Urabe, Y. et al. A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible loci at 5q35.3, 7p14.3, and 13q14.1. PLoS Genet. 8, e1002541 7 (2012).","journal-title":"PLoS Genet."},{"key":"332_CR86","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0802836","volume":"359","author":"Z Karim","year":"2008","unstructured":"Karim, Z. et al. NHERF1 mutations and responsiveness of renal parathyroid hormone. N. Engl. J. Med. 359, 1128\u20131135 (2008).","journal-title":"N. Engl. J. Med."},{"key":"332_CR87","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1074\/jbc.M008745200","volume":"276","author":"SM Gisler","year":"2001","unstructured":"Gisler, S. M. et al. Interaction of the type IIa Na\/Pi cotransporter with PDZ proteins. J. Biol. Chem. 276, 9206\u20139213 (2001).","journal-title":"J. Biol. Chem."},{"key":"332_CR88","doi-asserted-by":"crossref","first-page":"11470","DOI":"10.1073\/pnas.162232699","volume":"99","author":"S Shenolikar","year":"2002","unstructured":"Shenolikar, S., Voltz, J. W., Minkoff, C. M., Wade, J. B. & Weinman, E. J. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc. Natl Acad. Sci. USA 99, 11470\u201311475 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"332_CR89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2005","unstructured":"Bergwitz, C. et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am. J. Hum. Genet. 78, 179\u2013192 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"332_CR90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.285.5424.103","volume":"285","author":"DB Simon","year":"1999","unstructured":"Simon, D. B. et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+resorption. Science 285, 103\u2013106 (1999).","journal-title":"Science"},{"key":"332_CR91","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1681\/ASN.V1291872","volume":"12","author":"S Weber","year":"2001","unstructured":"Weber, S. et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J. Am. Soc. Nephrol. 12, 1872\u20131881 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR92","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ckj\/sfv081","volume":"8","author":"F Claverie-Martin","year":"2015","unstructured":"Claverie-Martin, F. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics. Clin. Kidney J. 8, 656\u2013664 (2015).","journal-title":"Clin. Kidney J."},{"key":"332_CR93","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jmedgenet-2016-103956","volume":"54","author":"PM Yamaguti","year":"2017","unstructured":"Yamaguti, P. M. et al. Amelogenesis imperfecta in familial hypomagnesaemia and hypercalciuria with nephrocalcinosis caused by CLDN19 gene mutations. J. Med. Genet. 54, 26\u201337 (2017).","journal-title":"J. Med. Genet."},{"key":"332_CR94","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/380418","volume":"73","author":"D M\u00fcller","year":"2003","unstructured":"M\u00fcller, D. et al. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am. J. Hum. Genet. 73, 1293\u20131301 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"332_CR95","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1086\/508617","volume":"79","author":"M Konrad","year":"2006","unstructured":"Konrad, M. et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am. J. Hum. Genet. 79, 949\u2013957 (2006).","journal-title":"J. Hum. Genet."},{"key":"332_CR96","doi-asserted-by":"crossref","first-page":"15350","DOI":"10.1073\/pnas.0907724106","volume":"106","author":"J Hou","year":"2009","unstructured":"Hou, J. et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc. Natl Acad. Sci. USA 106, 15350\u201315355 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"332_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI34628","volume":"118","author":"J Hou","year":"2008","unstructured":"Hou, J. et al. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J. Clin. Invest. 118, 1\u201311 (2008).","journal-title":"J. Clin. Invest."},{"key":"332_CR98","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1167\/iovs.11-8311","volume":"53","author":"S Peng","year":"2012","unstructured":"Peng, S., Gan, G., Rao, V. S., Adelman, R. A. & Rizzolo, L. J. Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 53, 5016\u20135028 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"332_CR99","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMoa1103864","volume":"365","author":"KP Schlingmann","year":"2011","unstructured":"Schlingmann, K. P. et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 365, 410\u2013421 (2011).","journal-title":"N. Engl. J. Med."},{"key":"332_CR100","doi-asserted-by":"crossref","first-page":"E1343","DOI":"10.1210\/jc.2014-4387","volume":"100","author":"A Molin","year":"2015","unstructured":"Molin, A. et al. CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait. J. Clin. Endocrinol. Metab. 100, E1343\u2013E1352 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"332_CR101","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ckj\/sfv028","volume":"8","author":"J Sayers","year":"2015","unstructured":"Sayers, J. et al. Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole. Clin. Kidney J. 8, 453\u2013455 (2015).","journal-title":"Clin. Kidney J."},{"key":"332_CR102","first-page":"167","volume":"7","author":"ED Peiris","year":"2018","unstructured":"Peiris, E. D. & Wusirika, R. A case report of compound heterozygous CYP24A1 mutations leading to nephrolithiasis successfully treated with ketoconazole. Case Rep. Nephrol. Dial. 7, 167\u2013171 (2018).","journal-title":"Case Rep. Nephrol. Dial."},{"key":"332_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00467-018-3998-z","volume":"33","author":"M Hureaux","year":"2018","unstructured":"Hureaux, M. et al. Prenatal hyperechogenic kidneys in three cases of infantile hypercalcemia associated with SLC34A1 mutations. Pediatr. Nephrol. 33, 1\u20137 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR104","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","volume":"26","author":"K Hopp","year":"2015","unstructured":"Hopp, K. et al. Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J. Am. Soc. Nephrol. 26, 2559\u20132570 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR105","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s11926-013-0340-4","volume":"15","author":"EC Lorenz","year":"2013","unstructured":"Lorenz, E. C., Michet, C. J., Milliner, D. S. & Lieske, J. C. Update on oxalate crystal disease. Curr. Rheumatol. Rep. 15, 1264\u20131269 (2013).","journal-title":"Curr. Rheumatol. Rep."},{"key":"332_CR106","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00726-010-0801-2","volume":"41","author":"AL Pey","year":"2010","unstructured":"Pey, A. L., Salido, E. & Sanchez-Ruiz, J. M. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria. Amino Acids 41, 1233\u20131245 (2010).","journal-title":"Amino Acids"},{"key":"332_CR107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ajt.14418","volume":"18","author":"T Dhondup","year":"2018","unstructured":"Dhondup, T., Lorenz, E. C., Milliner, D. S. & Lieske, J. C. Combined liver-kidney transplantation for primary hyperoxaluria type 2: a case report. Am. J. Transplant. 18, 253\u2013257 (2018).","journal-title":"Am. J. Transplant."},{"key":"332_CR108","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/8.11.2063","volume":"8","author":"SD Cramer","year":"1999","unstructured":"Cramer, S. D., Ferree, P. M., Lin, K., Milliner, D. S. & Holmes, R. P. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum. Mol. Genet. 8, 2063\u20132069 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"332_CR109","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1053\/ajkd.2001.29229","volume":"38","author":"CW Lam","year":"2001","unstructured":"Lam, C. W. et al. Novel mutation in the GRHPR gene in a Chinese patient with primary hyperoxaluria type 2 requiring renal transplantation from a living related donor. Am. J. Kidney Dis. 38, 1307\u20131310 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"332_CR110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026021","volume":"6","author":"TJ Riedel","year":"2011","unstructured":"Riedel, T. J. et al. Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. PLoS One 6, e26021 (2011).","journal-title":"PLoS One"},{"key":"332_CR111","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2215\/CJN.02760311","volume":"6","author":"CG Monico","year":"2011","unstructured":"Monico, C. G. et al. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin. J. Am. Soc. Nephrol. 6, 2289\u20132295 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"332_CR112","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ajhg.2016.03.026","volume":"98","author":"HY Gee","year":"2016","unstructured":"Gee, H. Y. et al. Mutations in SLC26A1 cause nephrolithiasis. Am. J. Hum. Genet. 98, 1228\u20131234 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"332_CR113","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI31474","volume":"120","author":"PA Dawson","year":"2010","unstructured":"Dawson, P. A. et al. Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice. J. Clin. Invest. 120, 706\u2013712 (2010).","journal-title":"J. Clin. Invest."},{"key":"332_CR114","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfs078","volume":"27","author":"P Cochat","year":"2012","unstructured":"Cochat, P. et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol. Dial. Transpl. 27, 1729\u20131736 (2012).","journal-title":"Nephrol. Dial. Transpl."},{"key":"332_CR115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.eeus.2006.06.001","volume":"4","author":"CS Biyani","year":"2006","unstructured":"Biyani, C. S. & Cartledge, J. J. Cystinuria \u2014 diagnosis and management. EAU-EBU Update Ser. 4, 175\u2013183 (2006).","journal-title":"EAU-EBU Update Ser."},{"key":"332_CR116","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/01.ASN.0000029586.17680.E5","volume":"13","author":"LD Strologo","year":"2002","unstructured":"Strologo, L. D. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J. Am. Soc. Nephrol. 13, 2547\u20132553 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR117","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jmg.2004.022244","volume":"42","author":"M Font-Llitjos","year":"2005","unstructured":"Font-Llitjos, M. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J. Med. Genet. 42, 58\u201368 (2005).","journal-title":"J. Med. Genet."},{"key":"332_CR118","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-2-48","volume":"2","author":"RJ Torres","year":"2007","unstructured":"Torres, R. J. & Puig, J. G. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J. Rare Dis. 2, 48 (2007).","journal-title":"Orphanet J. Rare Dis."},{"key":"332_CR119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0022-3476(69)80004-1","volume":"74","author":"WL Nyhan","year":"1969","unstructured":"Nyhan, W. L., James, J. A., Teberg, A. J., Sweetman, L. & Nelson, L. G. A new disorder of purine metabolism with behavioral manifestations. J. Pediatrics 74, 20\u201327 (1969).","journal-title":"J. Pediatrics"},{"key":"332_CR120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(82)91690-7","volume":"320","author":"HA Simmonds","year":"1982","unstructured":"Simmonds, H. A., Webster, D. R., Wilson, J. & Lingham, S. An X-linked syndrome characterised by hyperuricaemia, deafness, and neurodevelopmental abnormalities. Lancet 320, 68\u201370 (1982).","journal-title":"Lancet"},{"key":"332_CR121","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0925-4439(99)00103-9","volume":"1500","author":"E Zoref-Shani","year":"2000","unstructured":"Zoref-Shani, E., Feinstein, S., Frishberg, Y., Bromberg, Y. & Sperling, O. Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations. Biochim. Biophys. Acta 1500, 197\u2013203 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"332_CR122","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI108183","volume":"56","author":"E Zoref","year":"1975","unstructured":"Zoref, E., Vries, A. D. & Sperling, O. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts. J. Clin. Invest. 56, 1093\u20131099 (1975).","journal-title":"J. Clin. Invest."},{"key":"332_CR123","doi-asserted-by":"crossref","first-page":"26476","DOI":"10.1016\/S0021-9258(19)74339-7","volume":"268","author":"BJ Roessler","year":"1993","unstructured":"Roessler, B. J. et al. Human X-linked phosphoribosylpyrophosphate synthetase superactivity is associated with distinct point mutations in the PRPS1 gene. J. Biol. Chem. 268, 26476\u201326481 (1993).","journal-title":"J. Biol. Chem."},{"key":"332_CR124","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI109640","volume":"65","author":"MA Becker","year":"1980","unstructured":"Becker, M. A., Raivio, K. O., Bakay, B., Adams, W. B. & Nyhan, W. L. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions. J. Clin. Invest. 65, 109\u2013120 (1980).","journal-title":"J. Clin. Invest."},{"key":"332_CR125","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001","volume":"83","author":"H Matsuo","year":"2008","unstructured":"Matsuo, H. et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am. J. Hum. Genet. 83, 744\u2013751 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"332_CR126","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","volume":"15","author":"K Ichida","year":"2004","unstructured":"Ichida, K. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J. Am. Soc. Nephrol. 15, 164\u2013173 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028641","volume":"6","author":"V Tasic","year":"2011","unstructured":"Tasic, V. et al. Clinical and functional characterization of URAT1 variants. PLoS One 6, e28641 (2011).","journal-title":"PLoS One"},{"key":"332_CR128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1681\/ASN.2009040406","volume":"21","author":"D Dinour","year":"2010","unstructured":"Dinour, D. et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J. Am. Soc. Nephrol. 21, 64\u201372 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00467-018-4037-9","volume":"34","author":"N Ng","year":"2019","unstructured":"Ng, N., Kaur, A. & Shenoy, M. Recurrent kidney stones in a child with Lesch-Nyhan syndrome: answers. Pediatr. Nephrol. 34, 425\u2013427 (2019).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR130","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2013.08.025","volume":"127","author":"B Bhasin","year":"2014","unstructured":"Bhasin, B. et al. Hereditary renal hypouricemia: a new role for allopurinol? Am. J. Med. 127, e3\u2013e4 (2014).","journal-title":"Am. J. Med."},{"key":"332_CR131","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI119421","volume":"99","author":"K Ichida","year":"1997","unstructured":"Ichida, K. et al. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J. Clin. Invest. 99, 2391\u20132397 (1997).","journal-title":"J. Clin. Invest."},{"key":"332_CR132","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1006\/bbrc.2001.4719","volume":"282","author":"K Ichida","year":"2001","unstructured":"Ichida, K., Matsumura, T., Sakuma, R., Hosoya, T. & Nishino, T. Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II. Biochem. Biophys. Res. Commun. 282, 1194\u20131200 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"332_CR133","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2169\/internalmedicine1962.29.287","volume":"29","author":"A Nagae","year":"1990","unstructured":"Nagae, A. et al. Asymptomatic hereditary xanthinuria: a case report. Jpn. J. Med. 29, 287\u2013291 (1990).","journal-title":"Jpn. J. Med."},{"key":"332_CR134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(89)80083-6","volume":"115","author":"RD Fildes","year":"1989","unstructured":"Fildes, R. D. Hereditary xanthinuria with severe urolithiasis occurring in infancy as renal tubular acidosis and hypercalciuria. J. Pediatrics 115, 277\u2013280 (1989).","journal-title":"J. Pediatrics"},{"key":"332_CR135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/humu.21390","volume":"32","author":"J Reiss","year":"2010","unstructured":"Reiss, J. & Hahnewald, R. Molybdenum cofactor deficiency: mutations in GPHN, MOCS1, and MOCS2. Hum. Mutat. 32, 10\u201318 (2010).","journal-title":"Hum. Mutat."},{"key":"332_CR136","first-page":"714","volume":"20","author":"MS Zaki","year":"2016","unstructured":"Zaki, M. S. et al. Molybdenum cofactor and isolated sulphite oxidase deficiencies: clinical and molecular spectrum among Egyptian patients. Eur. J. Paediatr. Neuro. 20, 714\u2013722 (2016).","journal-title":"J. Paediatr. Neuro."},{"key":"332_CR137","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.ajkd.2015.10.023","volume":"67","author":"HL Runolfsdottir","year":"2016","unstructured":"Runolfsdottir, H. L., Palsson, R., Agustsdottir, I. M., Indridason, O. S. & Edvardsson, V. O. Kidney disease in adenine phosphoribosyltransferase deficiency. Am. J. Kidney Dis. 67, 431\u2013438 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"332_CR138","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1681\/ASN.2009080808","volume":"21","author":"G Boll\u00e9e","year":"2010","unstructured":"Boll\u00e9e, G. et al. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J. Am. Soc. Nephrol. 21, 679\u2013688 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR139","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00591080","volume":"75","author":"N Kamatani","year":"1987","unstructured":"Kamatani, N., Terai, C., Kuroshima, S., Nishioka, K. & Mikanagi, K. Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies. Hum. Genet. 75, 163\u2013168 (1987).","journal-title":"Hum. Genet."},{"key":"332_CR140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2017.10.007","volume":"48","author":"VO Edvardsson","year":"2018","unstructured":"Edvardsson, V. O. et al. Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency (APRTd): a clinical trial. Eur. J. Intern. Med. 48, 75\u201379 (2018).","journal-title":"Eur. J. Intern. Med."},{"key":"332_CR141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/cren.2017.0015","volume":"3","author":"A Jaffer","year":"2017","unstructured":"Jaffer, A., Joyce, A., Koenig, P. & Biyani, C. S. Adenine phosphoribosyltransferase deficiency: a rare cause of recurrent urolithiasis. J. Endourol. Case Rep. 3, 49\u201351 (2017).","journal-title":"J. Endourol. Case Rep."},{"key":"332_CR142","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ng.404","volume":"41","author":"G Thorleifsson","year":"2009","unstructured":"Thorleifsson, G. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat. Genet. 41, 926\u2013930 (2009).","journal-title":"Nat. Genet."},{"key":"332_CR143","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13145-x","volume":"10","author":"SA Howles","year":"2019","unstructured":"Howles, S. A. et al. Genetic variants of calcium and vitamin D metabolism in kidney stone disease. Nat. Commun. 10, 5175 (2019).","journal-title":"Nat. Commun."},{"key":"332_CR144","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1681\/ASN.2018090942","volume":"30","author":"C Tanikawa","year":"2019","unstructured":"Tanikawa, C. et al. Novel risk loci identified in a genome-wide association study of urolithiasis in a Japanese population. J. Am. Soc. Nephrol. 30, 855\u2013864 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR145","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/8e7ba8d6-a174-4a3a-93b4-510d5ca7ed1e","volume":"6","author":"DF Gudbjartsson","year":"2010","unstructured":"Gudbjartsson, D. F. et al. Association of variants at UMOD with chronic kidney disease and kidney stones \u2014 role of age and comorbid diseases. PLoS Genet. 6, e1001039 (2010).","journal-title":"PLoS Genet."},{"key":"332_CR146","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddy409","volume":"28","author":"S Benonisdottir","year":"2019","unstructured":"Benonisdottir, S. et al. Sequence variants associating with urinary biomarkers. Hum. Mol. Genet. 28, 1199\u20131211 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"332_CR147","doi-asserted-by":"crossref","first-page":"e71885","DOI":"10.1371\/journal.pone.0071885","volume":"8","author":"HR Toka","year":"2013","unstructured":"Toka, H. R., Genovese, G., Mount, D. B., Pollak, M. R. & Curhan, G. C. Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion. PLoS One 8, e71885\u2013e71888 (2013).","journal-title":"PLoS One"},{"key":"332_CR148","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/humu.23202","volume":"38","author":"ME Ure","year":"2017","unstructured":"Ure, M. E. et al. A variant in a cis-regulatory element enhances claudin-14 expression and is associated with pediatric-onset hypercalciuria and kidney stones. Hum. Mutat. 38, 649\u2013657 (2017).","journal-title":"Hum. Mutat."},{"key":"332_CR149","doi-asserted-by":"crossref","first-page":"F761","DOI":"10.1152\/ajprenal.00263.2012","volume":"304","author":"H Dimke","year":"2013","unstructured":"Dimke, H. et al. Activation of the Ca2+-sensing receptor increases renal claudin-14 expression and urinary Ca2+ excretion. Am. J. Physiol. Renal Physiol. 304, F761\u2013F769 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"332_CR150","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.ki.5002156","volume":"71","author":"G Vezzoli","year":"2007","unstructured":"Vezzoli, G. et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 71, 1155\u20131162 (2007).","journal-title":"Kidney Int."},{"key":"332_CR151","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/01.ASN.0000030077.72157.D2","volume":"13","author":"G Vezzoli","year":"2002","unstructured":"Vezzoli, G. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J. Am. Soc. Nephrol. 13, 2517\u20132523 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"332_CR152","first-page":"958207","volume":"2015","author":"K Liu","year":"2015","unstructured":"Liu, K. et al. The G allele of CaSR R990G polymorphism increases susceptibility to urolithiasis and hypercalciuria: evidences from a comprehensive meta-analysis. Biomed. Res. Int. 2015, 958207\u2013958212 (2015).","journal-title":"Biomed. Res. Int."},{"key":"332_CR153","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1523-1755.2000.00138.x","volume":"58","author":"M Petrucci","year":"2000","unstructured":"Petrucci, M. et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int. 58, 38\u201342 (2000).","journal-title":"Kidney Int."},{"key":"332_CR154","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/gtmb.2017.0208","volume":"22","author":"X Li","year":"2018","unstructured":"Li, X. et al. Common variants in ALPL gene contribute to the risk of kidney stones in the Han Chinese population. Genet. Test. Mol. Biomarkers 22, 187\u2013192 (2018).","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"332_CR155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. Hypophosphatasia \u2014 aetiology, nosology, pathogenesis, diagnosis and treatment. Nat. Rev. Endocrinol. 12, 233\u2013246 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"332_CR156","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI200319826","volume":"112","author":"JGJ Hoenderop","year":"2003","unstructured":"Hoenderop, J. G. J. et al. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112, 1906\u20131914 (2003).","journal-title":"J. Clin. Invest."},{"key":"332_CR157","volume":"8","author":"NY Loh","year":"2013","unstructured":"Loh, N. Y. et al. Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5. PLoS One 8, e55412 (2013).","journal-title":"PLoS One"},{"key":"332_CR158","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbrc.2017.08.102","volume":"492","author":"L Wang","year":"2017","unstructured":"Wang, L., Holmes, R. P. & Peng, J.-B. The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5. Biochem. Biophys. Res. Commun. 492, 362\u2013367 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"332_CR159","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/ndt\/gfn735","volume":"24","author":"KY Renkema","year":"2009","unstructured":"Renkema, K. Y. et al. TRPV5 gene polymorphisms in renal hypercalciuria. Nephrol. Dial. Transpl. 24, 1919\u20131924 (2009).","journal-title":"Nephrol. Dial. Transpl."},{"key":"332_CR160","doi-asserted-by":"crossref","first-page":"375427","DOI":"10.1155\/2015\/375427","volume":"2015","author":"A Khaleel","year":"2015","unstructured":"Khaleel, A. et al. A single nucleotide polymorphism (rs4236480) in TRPV5 calcium channel gene is associated with stone multiplicity in calcium nephrolithiasis patients. Mediators Inflamm. 2015, 375427 (2015).","journal-title":"Mediators Inflamm."},{"key":"332_CR161","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.juro.2016.01.093","volume":"196","author":"X Lu","year":"2016","unstructured":"Lu, X. et al. Urolithiasis\/endourology in silico screening and molecular dynamic study of nonsynonymous single nucleotide polymorphisms associated with kidney stones in the SLC26A6 gene. J. Urol. 196, 118\u2013123 (2016).","journal-title":"J. Urol."},{"key":"332_CR162","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/hmg\/ddn048","volume":"17","author":"Y Suzuki","year":"2008","unstructured":"Suzuki, Y. et al. Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum. Mol. Genet. 17, 1613\u20131618 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"332_CR163","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ng1762","volume":"38","author":"Z Jiang","year":"2006","unstructured":"Jiang, Z. et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat. Genet. 38, 474\u2013478 (2006).","journal-title":"Nat. Genet."},{"key":"332_CR164","volume":"6","author":"H Jiang","year":"2018","unstructured":"Jiang, H. et al. High expression of SLC26A6 in the kidney may contribute to renal calcification via an SLC26A6-dependent mechanism. PeerJ 6, e5192 (2018).","journal-title":"PeerJ"},{"key":"332_CR165","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1464-410X.2007.06792.x","volume":"99","author":"C-C Liu","year":"2007","unstructured":"Liu, C.-C. et al. Association of vitamin D receptor (Fok-I) polymorphism with the clinical presentation of calcium urolithiasis. BJU Int. 99, 1534\u20131538 (2007).","journal-title":"BJU Int."},{"key":"332_CR166","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/109153601750124203","volume":"5","author":"WC Chen","year":"2001","unstructured":"Chen, W. C., Chen, H. Y., Hsu, C. D., Wu, J. Y. & Tsai, F. J. No association of vitamin D receptor gene BsmI polymorphisms with calcium oxalate stone formation. Mol. Urol. 5, 7\u201310 (2001).","journal-title":"Mol. Urol."},{"key":"332_CR167","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00240-005-0033-1","volume":"34","author":"S Gunes","year":"2006","unstructured":"Gunes, S. et al. Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol. Res. 34, 47\u201352 (2006).","journal-title":"Urol. Res."},{"key":"332_CR168","first-page":"694","volume":"27","author":"MJ Moyano","year":"2007","unstructured":"Moyano, M. J. et al. Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results. Nefrologia 27, 694\u2013703 (2007).","journal-title":"Nefrologia"},{"key":"332_CR169","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00467-005-1846-4","volume":"20","author":"HK Bid","year":"2005","unstructured":"Bid, H. K., Chaudhary, H. & Mittal, R. D. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr. Nephrol. 20, 773\u2013776 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"332_CR170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/end.1999.13.313","volume":"13","author":"SV Jackman","year":"1999","unstructured":"Jackman, S. V. et al. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J. Endourol. 13, 313\u2013316 (1999).","journal-title":"J. Endourol."},{"key":"332_CR171","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000057443","volume":"25","author":"M Ruggiero","year":"1999","unstructured":"Ruggiero, M., Pacini, S., Amato, M., Aterini, S. & Chiarugi, V. Association between vitamin D receptor gene polymorphism and nephrolithiasis. Miner. Electrolyte Metab. 25, 185\u2013190 (1999).","journal-title":"Miner. Electrolyte Metab."},{"key":"332_CR172","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00240-013-0619-y","volume":"42","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Vitamin D receptor gene (VDR) polymorphisms and the urolithiasis risk: an updated meta-analysis based on 20 case\u2013control studies. Urolithiasis 42, 45\u201352 (2013).","journal-title":"Urolithiasis"},{"key":"332_CR173","volume":"14","author":"P Zhang","year":"2013","unstructured":"Zhang, P., Nie, W. & Jiang, H. Effects of vitamin D receptor polymorphisms on urolithiasis risk: a meta-analysis. BMC Med. Genet. 14, 104 (2013).","journal-title":"BMC Med. Genet."},{"key":"332_CR174","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gene.2018.02.020","volume":"653","author":"H Lin","year":"2018","unstructured":"Lin, H. et al. HIPK2 polymorphisms rs2058265, rs6464214, and rs7456421 were associated with kidney stone disease in Chinese males not females. Gene 653, 51\u201356 (2018).","journal-title":"Gene"},{"key":"332_CR175","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cca.2010.02.007","volume":"411","author":"C-C Liu","year":"2010","unstructured":"Liu, C.-C. et al. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin. Chim. Acta 411, 739\u2013743 (2010).","journal-title":"Clin. Chim. Acta"},{"key":"332_CR176","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00240-013-0582-7","volume":"41","author":"MR Safarinejad","year":"2013","unstructured":"Safarinejad, M. R., Shafiei, N. & Safarinejad, S. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis. Urolithiasis 41, 303\u2013313 (2013).","journal-title":"Urolithiasis"},{"key":"332_CR177","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.juro.2007.01.118","volume":"177","author":"B Gao","year":"2007","unstructured":"Gao, B. et al. A polymorphism of matrix Gla protein gene is associated with kidney stones. J. Urol. 177, 2361\u20132365 (2007).","journal-title":"J. Urol."},{"key":"332_CR178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.gene.2012.09.112","volume":"511","author":"X Lu","year":"2012","unstructured":"Lu, X. et al. A polymorphism of matrix Gla protein gene is associated with kidney stone in the Chinese Han population. Gene 511, 127\u2013130 (2012).","journal-title":"Gene"},{"key":"332_CR179","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080344","volume":"8","author":"M Goiko","year":"2013","unstructured":"Goiko, M. et al. Peptides of matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals. PLoS One 8, e80344 (2013).","journal-title":"PLoS One"},{"key":"332_CR180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3892\/br.2013.73","volume":"1","author":"D Li","year":"2013","unstructured":"Li, D. et al. Meta-analysis of the urokinase gene 3\u2032-UTR T\/C polymorphism and susceptibility to urolithiasis. Biomed. Rep. 1, 369\u2013374 (2013).","journal-title":"Biomed. Rep."},{"key":"332_CR181","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.kint.2017.08.023","volume":"93","author":"CB Langman","year":"2018","unstructured":"Langman, C. B. A rational approach to the use of sophisticated genetic analyses of pediatric stone disease. Kidney Int. 93, 15\u201318 (2018).","journal-title":"Kidney Int."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41585-020-0332-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-020-0332-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-020-0332-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:44:17Z","timestamp":1684604657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-020-0332-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":181,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1038\/s41585-020-0332-x","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"4 May 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}